Merit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 9.51%, EPS grew 18.2%, free cash flow fell 25.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow MMSI
Merit Medical Systems, Inc. (MMSI) EV/Sales
As of 16 October 2026, Merit Medical Systems, Inc. (MMSI) trades at a EV/Sales of 3.6×. Over the past ten years it has ranged from 1.6× (October 2019) to 5.0× (January 2025); the current reading is higher than 59% of that period. That is above the Medical Instruments & Supplies industry median of 2.9× and in line with the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.6× | (17.71%) |
| FY2024 | 4.4× | 19.64% |
| FY2023 | 3.7× | 3.73% |
| FY2022 | 3.6× | 4.06% |
| FY2021 | 3.4× | (2.30%) |
| FY2020 | 3.5× | 64.56% |
| FY2019 | 2.1× | (42.18%) |
| FY2018 | 3.7× | 12.82% |
| FY2017 | 3.3× | 33.96% |
| FY2016 | 2.4× | 29.02% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.8× | (0.58%) |
| Mar 2026 | 2.8× | (22.30%) |
| Dec 2025 | 3.6× | 1.70% |
| Sep 2025 | 3.6× | (13.60%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVST Envista Holdings Corporation compare | 1.4× |
| BLCO Bausch + Lomb Corporation compare | 2.0× |
| ATR AptarGroup, Inc. compare | 2.3× |
| ICUI ICU Medical, Inc. compare | 2.3× |
| WRBY Warby Parker Inc. compare | 2.9× |
| MMSI Merit Medical Systems, Inc. | 3.6× |
| TFX Teleflex Incorporated compare | 3.6× |
| STVN Stevanato Group S.p.A. compare | 3.9× |
| PLSE Pulse Biosciences, Inc compare | 2,555× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)